Clayton I. Duncan - founder and CEO & chairman @ Pamlico Biopharma

Overview

Number of Founded Organizations

CB Rank (Investor)

Clayton Duncan joined Valanbio Therapeutics as CEO in 2018.

Number of Current Jobs

Number of Past Jobs

has

current jobs including

CEO

Chairman and Chief Executive Officer

, and

CEO

. Additionally,

has had

past jobs including

CEO

Organization Name	Title At Company	Start Date	End Date
Sphinx Pharmaceuticals	CEO	1989	1994
Vindicia	CEO	—	—
i2E	Entrepreneur In Residence	—	—

Number of Past Board & Advisor Roles

Organization Name	Title At Company	Start Date	End Date
Synereca Pharmaceuticals	Chairman	Jul 2009	Sep 2017

Hub Name	CB Rank (Hub)
Closed Biotechnology Companies	9,202
Closed Clinical Trials Companies	60,088
Closed Southern US Biotechnology Companies	24,455
Closed Southern US Health Care Companies	10,780
Closed United States Health Care Companies (Top 10K)	4,212
Closed Biopharma Companies	37,891
Closed United States Biotechnology Companies	8,128
Startups Founded in 2011 That Failed	3,150

studied at

and

There is no recent news or activity for this profile.